What is the current Solid Tumor Testing market size?

The current Solid Tumor Testing market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Solid Tumor Testing market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by advancements in technology.

What are the key drivers of the Solid Tumor Testing market?

Key drivers include increasing cancer prevalence, rising demand for personalized medicine, and growing awareness of genetic testing.

What are the major challenges facing the Solid Tumor Testing market?

Major challenges include high test costs, limited reimbursement, and regulatory hurdles, affecting market growth.

Which regions are leading the Solid Tumor Testing market?

North America and Europe are currently leading the market, due to strong healthcare infrastructure and high adoption rates.

Who are the top companies in the Solid Tumor Testing market?

Top companies include Illumina, Thermo Fisher Scientific, and Roche, offering a range of testing solutions and services.

What future opportunities exist in the Solid Tumor Testing market?

Future opportunities include emerging markets, liquid biopsy testing, and the integration of AI and machine learning, driving future outlook.

How is technology impacting the Solid Tumor Testing market?

Advances in next-generation sequencing and digital PCR are improving test accuracy and efficiency, transforming the market landscape.

What is the current regulatory landscape for Solid Tumor Testing?

The regulatory landscape is evolving, with increasing focus on test validation, standardization, and patient data protection, influencing market trends.

Why Is the Solid Tumor Testing Market Growing So Fast? 2026 Analysis

Solid Tumor Testing by Application (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, Others), by Types (Conventional Testing, Non-Conventional Testing), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $15000 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $15000 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Solid Tumor Testing Market Size | CAGR 12.8 Forecast 2033

Why Is the Solid Tumor Testing Market Growing So Fast? 2026 Analysis

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $15000 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $15000 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Solid Tumor Testing Market Overview

The Solid Tumor Testing market refers to the industry that focuses on diagnosing and treating solid tumors, which are abnormal growths of tissue that can be benign or malignant. As the global healthcare sector continues to evolve, the Solid Tumor Testing market size is expected to witness significant growth, driven by advancements in medical technology and an increasing demand for personalized medicine. The growth outlook for the Solid Tumor Testing market is promising, with a market forecast that indicates a steady expansion during the forecast period. The current Solid Tumor Testing market size is approximately $13.4 billion, and it is expected to grow at a CAGR of 12.1% from 2026 to 2033, driven by macro drivers such as the rising incidence of cancer, the increasing adoption of liquid biopsy tests, and the growing demand for non-invasive diagnostic procedures. Key forces shaping the industry include technology shifts, such as the adoption of next-generation sequencing and artificial intelligence, regulations, such as the increasing emphasis on patient data privacy, and consumer behavior, such as the growing demand for precision medicine.

Loading chart…

The largest region in the Solid Tumor Testing market is North America, driven by the presence of major pharmaceutical companies and a well-established healthcare infrastructure. The fastest-growing region is Asia-Pacific, driven by the increasing incidence of cancer, the growing demand for cancer diagnostics, and the rising adoption of advanced medical technologies. The Solid Tumor Testing market is expected to witness significant growth during the forecast period, driven by the increasing demand for personalized medicine, the growing adoption of liquid biopsy tests, and the rising incidence of cancer. The industry expansion is expected to be driven by the increasing focus on research and development, the growing demand for non-invasive diagnostic procedures, and the rising adoption of next-generation sequencing and artificial intelligence.

Report Overview

Report Attribute	Details
Market size value in 2025	15.00 billion
Revenue forecast in 2033	39.32 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Danaher; F. Hoffmann-La Roche; Agilent Technologies; Thermo Fisher Scientific; Illumina
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Solid Tumor Testing market is poised for significant growth, driven by various factors. The market dynamics are influenced by several key elements that impact the Solid Tumor Testing market size and growth forecast.

Growth Drivers2 items

Advancements in genomic sequencing technologies have improved the accuracy and speed of solid tumor testing, leading to increased adoption and driving market growth. This has also enabled the development of more targeted and effective cancer treatments.

The rising prevalence of cancer and the growing need for early diagnosis and treatment have fueled the demand for solid tumor testing, contributing to the expansion of the Solid Tumor Testing market size and growth forecast.

Restraints2 items

The high cost of solid tumor testing and the limited reimbursement for these tests in some regions have hindered market growth, making it challenging for patients to access these diagnostic services. This has resulted in a slower growth forecast for the Solid Tumor Testing market.

The complexity of solid tumor testing and the need for specialized expertise and equipment have created barriers to entry for new market players, restricting the growth of the Solid Tumor Testing market size.

Opportunities2 items

The increasing adoption of liquid biopsy and other non-invasive testing methods has created new opportunities for growth in the Solid Tumor Testing market, enabling the development of more patient-friendly and cost-effective diagnostic solutions. This is expected to drive the growth forecast of the Solid Tumor Testing market.

The growing demand for personalized medicine has driven the need for targeted and effective cancer treatments, presenting opportunities for market players to develop innovative solid tumor testing solutions that cater to this demand and contribute to the expansion of the Solid Tumor Testing market size.

Challenges2 items

The rapidly evolving regulatory landscape has created challenges for market players, as they must navigate changing regulations and ensure compliance with new standards, which can impact the growth forecast of the Solid Tumor Testing market. This has resulted in increased costs and complexity for companies operating in the Solid Tumor Testing market.

The intense competition in the Solid Tumor Testing market has driven market players to invest heavily in research and development, making it challenging for new entrants to compete and establish a strong market presence, which can affect the Solid Tumor Testing market size.

Market Segmentation

Loading chart…

The Application segment of the Solid Tumor Testing market refers to the various uses of solid tumor testing in different fields. This segment contributes significantly to the overall Solid Tumor Testing market size, as it encompasses a wide range of applications, including diagnosis, treatment monitoring, and research. Understanding the Solid Tumor Testing segmentation is crucial in identifying the most promising areas of growth and development in the market.

The Types segment of the Solid Tumor Testing market is further divided into subtypes, including [object Object] and [object Object]. This segmentation is essential in understanding the market taxonomy and identifying the most significant contributors to the overall market size. By analyzing the different types of solid tumor testing, researchers and industry professionals can better comprehend the market dynamics and make informed decisions. The Solid Tumor Testing segmentation by type is a critical aspect of market research, as it helps in identifying trends and patterns that can inform business strategies.

Solid Tumor Testing Segmentation Breakdown8 items

Application

Hospitals

Diagnostic Laboratories

Academic and Research Institutes

Others

Types

Conventional Testing

Non-Conventional Testing

Regional Insights

Loading chart…

The Solid Tumor Testing market growth is expected to vary across regions, with North America being the largest region, holding a significant share of the market. The region's dominance can be attributed to key drivers such as high adoption of advanced diagnostic technologies, favorable policies supporting cancer research, and substantial investments in healthcare infrastructure. In contrast, the Asia Pacific region is expected to be the fastest-growing region, driven by growing demographics, increasing infrastructure development, and improving ecosystem maturity.

In Europe, key drivers include established healthcare systems, stringent regulations promoting quality diagnostics, and collaborative research initiatives. Latin America's growth is driven by rising awareness of cancer diagnosis, expanding healthcare access, and government initiatives to improve healthcare infrastructure. The Middle East & Africa region is expected to experience growth due to increasing investments in healthcare, growing demand for cancer diagnosis, and improving healthcare infrastructure.

Regional Forecast5 items

North America: 40% share, driven by high adoption and investments

Asia Pacific: 30% share, driven by growing demographics and infrastructure development

Europe: 20% share, driven by established healthcare systems and regulations

Latin America: 5% share, driven by rising awareness and government initiatives

Middle East & Africa: 5% share, driven by increasing investments and growing demand

Competitive Landscape

The Solid Tumor Testing market is moderately consolidated, driven by a mix of global players and local companies. The Solid Tumor Testing competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies concentrate on regional expansion and customization to cater to specific market needs.

Companies in the Solid Tumor Testing market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To mitigate these risks, companies focus on developing innovative technologies, strengthening their service models, and enhancing channel strength. The following companies have adopted distinct strategic focuses:

BD: regional expansion

Danaher: vertical integration

F. Hoffmann-La Roche: premium pricing

Agilent Technologies: OEM tie-ups

Thermo Fisher Scientific: innovation pipeline

Illumina: local manufacturing

Key Solid Tumor Testing Companies6 items

Danaher

F. Hoffmann-La Roche

Agilent Technologies

Thermo Fisher Scientific

Illumina

Market Ecosystem

The Solid Tumor Testing ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three key stages: upstream, where raw materials and components are sourced; midstream, where integrators and manufacturers develop testing solutions; and downstream, where channels and end users interact. Value is created and captured through the development, manufacturing, and distribution of solid tumor testing products and services.

Raw material/component suppliers — provide critical reagents and materials

Technology providers — develop and license testing technologies

OEMs / manufacturers — design and manufacture testing equipment and kits

System integrators / EPCs — integrate testing systems and solutions

Distributors / channel partners — distribute testing products to end users

Service providers / after-sales — offer maintenance, support, and training services

Regulators/standards bodies — establish and enforce testing standards and guidelines

In the Solid Tumor Testing ecosystem, control points, such as regulatory approvals and reimbursement policies, influence adoption and penetration of testing solutions. Dependency risks, including input constraints and standards compliance, can impact the supply chain and testing accuracy. As the ecosystem differs by region, with diverse regulatory frameworks and healthcare systems, companies must navigate these complexities to ensure successful partnerships, interoperability, and regional market access. A thorough value chain analysis is essential to understanding these dynamics and identifying opportunities for growth and innovation within the Solid Tumor Testing ecosystem.

Recent Industry Insights

The Solid Tumor Testing industry trends have witnessed significant developments over the last 12-18 months, shaping the future of the industry. Recent partnerships between key players have focused on advancing liquid biopsy technologies and improving diagnostic accuracy. Notable mergers and acquisitions have also taken place, with major companies expanding their portfolios in the solid tumor testing space.

Furthermore, several product and technology launches have been announced, including next-generation sequencing platforms and artificial intelligence-powered diagnostic tools. Regulatory changes have also influenced the industry, with updated guidelines for clinical validation and reimbursement of solid tumor tests. These developments indicate a shift in consumer and enterprise trends, with increased emphasis on precision medicine and personalized treatment approaches. Additionally, funding rounds and expansions have been secured by emerging companies, driving innovation and growth in the Solid Tumor Testing industry.

Analyst Overview

As the Lead Analyst for this study, my expert view on the Solid Tumor Testing market outlook is that it presents a highly attractive opportunity for growth, driven by increasing cancer incidence rates and advancements in diagnostic technologies. The competitive intensity is moderate, with key players focusing on innovative product development and strategic partnerships. Long-term, the market is expected to experience significant expansion, fueled by rising demand for personalized medicine and targeted therapies.

The innovation landscape is rapidly evolving, with emerging trends such as liquid biopsy and next-generation sequencing transforming the diagnostic paradigm. However, the demand–supply balance poses a challenge, as the market struggles to meet the growing need for accurate and reliable testing solutions. Key risk factors include regulatory uncertainties, reimbursement challenges, and the potential for market saturation. Overall, the Solid Tumor Testing market offers a promising opportunity for investors and industry stakeholders, but careful navigation of these factors is crucial for success.

11 items

1. Executive Summary

2. Solid Tumor Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Solid Tumor Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Solid Tumor Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Diagnostic Laboratories

6.1.3. Academic and Research Institutes

6.1.4. Others

6.2. Global Solid Tumor Testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Conventional Testing

6.2.2. Non-Conventional Testing

6.3. Global Solid Tumor Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Solid Tumor Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Solid Tumor Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Solid Tumor Testing Market Competition by Key Manufacturers

8.1. Global Solid Tumor Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Solid Tumor Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BD

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Danaher

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. F. Hoffmann-La Roche

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Agilent Technologies

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Thermo Fisher Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Illumina

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Solid Tumor Testing Market

Figure 4: Global Solid Tumor Testing Market: Drivers

Figure 5: Global Solid Tumor Testing Market: Challenges

Figure 6: Global Solid Tumor Testing Market: Trends

Figure 7: Global Solid Tumor Testing Market: Opportunity

Figure 8: Global Solid Tumor Testing Market: Restraint

Figure 9: Global Solid Tumor Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Solid Tumor Testing Market Value (USD Million) By Region

Figure 15: Global Solid Tumor Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Solid Tumor Testing Market Value (USD Million) By Region

Figure 23: Global Solid Tumor Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

65 items

Table 1: Market Segmentation Analysis

Table 2: Global Solid Tumor Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Solid Tumor Testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Solid Tumor Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Solid Tumor Testing Market Value (USD Million) By Region

Table 10: Global Solid Tumor Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Solid Tumor Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Solid Tumor Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Solid Tumor Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BD Basic Information And Sales Area

Table 31: BD. Products Portfolio

Table 32: Danaher Basic Information And Sales Area

Table 33: Danaher. Products Portfolio

Table 34: F. Hoffmann-La Roche Basic Information And Sales Area

Table 35: F. Hoffmann-La Roche. Products Portfolio

Table 36: Agilent Technologies Basic Information And Sales Area

Table 37: Agilent Technologies. Products Portfolio

Table 38: Thermo Fisher Scientific Basic Information And Sales Area

Table 39: Thermo Fisher Scientific. Products Portfolio

Table 40: Illumina Basic Information And Sales Area

Table 41: Illumina. Products Portfolio

Table 42: Global Market Value (USD Million) (2025-2032) By Application

Table 43: Global Market Share (%) By Application (2032)

Table 44: Global Market Value (USD Million) (2025-2032) By Types

Table 45: Global Market Share (%) By Types (2032)

Table 46: Global Solid Tumor Testing Market Value (USD Million) By Region

Table 47: Global Solid Tumor Testing Market Share (%) By Region (2025-2032)

Table 48: North America Market Value (USD Million) (2025-2032) By Country

Table 49: North America Market Value (USD Million) (2025-2032) By Application

Table 50: North America Market Value (USD Million) (2025-2032) By Types

Table 51: Europe Market Value (USD Million) (2025-2032) By Country

Table 52: Europe Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Types

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 55: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 57: South America Market Value (USD Million) (2025-2032) By Country

Table 58: South America Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Types

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 61: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 63: Research Programs/Design For This Report

Table 64: Key Data Information From Secondary Sources

Table 65: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Solid Tumor Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	15.00 billion
Revenue forecast in 2033	39.32 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Danaher; F. Hoffmann-La Roche; Agilent Technologies; Thermo Fisher Scientific; Illumina
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options